The guideline includes additional stool-based tests: an upgraded version of Cologuard, called Cologuard Plus, and a new FDA-approved test called ColoSense, which was developed by the biotech company Geneoscopy. Each is an at-home stool test, in which samples are collected at home and sent to a lab, where the test can detect molecular markers associated with colorectal cancer…
